NCT07231575 2025-11-18Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLCSun Yat-sen UniversityPhase 2 Not yet recruiting39 enrolled
NCT07205497 2025-10-03QNACTHSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 2 Active not recruiting54 enrolled